Skip to main content
Neurology

<![CDATA[Emerging CAR-T Strategies in MG]]>

Post Content: Source: Neurology Read More
Neurology

<![CDATA[What Asundexian’s Approval Means for Secondary Stroke Prevention at the Bedside: Ashkan Shoamanesh, MD]]>

Post Content: Source: Neurology Read More
Neurology

<![CDATA[Understanding the Long-Term Effects of Traumatic Brain Injury in Military Personnel: Clayton Mucha, MD]]>

Post Content: Source: Neurology Read More
Neurology
<![CDATA[How Asundexian’s Approval Could Reshape Antithrombotic Therapy in Noncardioembolic Stroke: Mike Sharma, MD, MSc]]>
Neurology
<![CDATA[MS Feedback Loops and Heterogeneity: Why Disease Course Varies]]>
Neurology
<![CDATA[Recognizing Inadequate Response to FcRn Inhibitors in MG]]>
Neurology
<![CDATA[New CTE Prevalence Estimate Underscores Push for Diagnosis Living Patients]]>
Neurology
<![CDATA[Understanding the Role of TAPS Therapy in Essential Tremor Management: Stuart H. Isaacson, MD, FAAN]]>
Neurology
<![CDATA[Consistent TAPS Use Associated With Underlying Tremor Improvement in Essential Tremor]]>
admin
By In Pyschiatry

What APA Is Doing for You: Update on Clozapine REMS

In November 2021, the Food and Drug Administration (FDA) instituted a new Clozapine Risk Evaluation and Mitigation Strategy (REMS) to…
Read More
Visit Our Podcast

Oncology Overdrive